Treating severe COVID-19 patients with the anticancer drug bevacizumab may reduce mortality and speed up recovery, according to a small clinical study in Italy and China that was led by researchers at Karolinska Institutet ...
Feb 5, 2021
0
105
A Kobe University research group including graduate student Ishii Shinichi and Associate Professor Katayama Yoshio (both of the Department of Hematology, Graduate School of Medicine) have discovered that fibroblast growth ...
Jan 19, 2021
0
0
A key symptom of COVID-19—oxygen saturation—is now being estimated remotely from a camera, thanks to research from University of South Australia engineers Professor Javaan Chahl, Dr. Ali Al-Naji and their team of graduate ...
Nov 20, 2020
0
1
Scientists are still solving the many puzzling aspects of how the novel coronavirus attacks the lungs and other parts of the body. One of the biggest and most life-threatening mysteries is how the virus causes "silent hypoxia," ...
Nov 19, 2020
0
37
Do you own an oximeter? If so, do you know how and when to use it? It could save your life.
Nov 6, 2020
0
6
One way CBD appears to reduce the "cytokine storm" that damages the lungs and kills many patients with COVID-19 is by enabling an increase in levels of a natural peptide called apelin, which is known to reduce inflammation ...
Oct 19, 2020
0
23
A new pilot study from the Icahn School of Medicine at Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries. This vasodilation is contributing to ...
Aug 19, 2020
0
2
When the eye isn't getting enough oxygen in the face of common conditions like premature birth or diabetes, it sets in motion a state of frenzied energy production that can ultimately result in blindness, and now scientists ...
Aug 10, 2020
0
117
With cases of COVID-19 on the rise, many Australians are asking: what happens if I test positive? With no known cure and no vaccine, what are my treatment options?
Aug 5, 2020
0
6
Researchers at the University of Illinois at Chicago have found that interleukin 1 beta, a protein known to activate immune responses, can disrupt signaling proteins leading to acute respiratory distress syndrome, or ARDS.
Jun 25, 2020
0
4
